The portable ultrasound scanner is getting an indispensable tool in nephrology for patients waiting for kidney transplantation.

The repeated dialyses indeed require the regular insertion of catheters and therefore also a risk of damaging the veins. A strengthening of the vein can then be made. It is very important to check the vascularization of the vessels at this exact place by ultrasound scanning and also to measure the arterial blood flow.
The ultrasound scanners EXAGO and EXAGYNE are the perfect devices for nephrology. The very good B image quality enables an excellent visualization of the anatomical structures. The high Doppler sensitivity in both colour Doppler and Pulsed Wave is also appreciated for checking the vascularization. The automatic measurement of blood flow that is always included on EXAGO and EXAGYNE is also a precious advantage for the physician in the everyday work. Furthermore, the automatic, quick and very intuitive measurement of IMT (Intima Media Thickness) on both EXAGO and EXAGYNE is also an important tool that is used as a standard in nephrology.

EXAGO, the ultra-portable scanner weighs only 3.2 kg and boots up in 20 seconds. It provides a high-quality image with an excellent contrast and also both colour Doppler and Pulsed Wave. EXAGO works on battery with an excellent autonomy that enables you to work for more than 5 hours without any concern about electricity.
EXAGYNE is the portable scanner with a very good image quality and a good Doppler with a remarkable sensitivity. EXAGYNE has specific and easy presets. Because of the real triplex mode (B mode/CFM colour Flow Mapping/PW Pulsed Wave simultaneously and in real time) on EXAGYNE, it is possible to visualize all anatomical details in B mode, to control the blood flows in CFM and to measure the flow speed in PW, all at the same time. EXAGYNE has two probe connectors directly on the device and therefore enables you to go very fast from a superficial exploration to an examination of the kidneys in depth.

Discover our products adapted to this clinical application